found that low levels of TLN2 notably correlated with shorter survival rates and tumor aggressiveness in patients with ccRCC, and TLN2 strongly correlated with ccRCC proliferation, migration, and invasion via regulation of the Wnt/β‐catenin pathway.54 This evidence concerns the gene TLN2 and nonpapillary renal cell carcinoma.